Bi-allelic loss of function variants in SLC30A5 as cause of perinatal lethal cardiomyopathy.
Johann Kaspar LieberwirthPascal JosetAnja HeinzeJulia HentschelAnja SteinAntonella IannacconeKatharina SteindlAlma KuechlerRami Abou JamraPublished in: European journal of human genetics : EJHG (2021)
Perinatal mortality is a heavy burden for both affected parents and physicians. However, the underlying genetic causes have not been sufficiently investigated and most cases remain without diagnosis. This impedes appropriate counseling or therapy. We describe four affected children of two unrelated families with cardiomyopathy, hydrops fetalis, or cystic hygroma that all deceased perinatally. In the four patients, we found the following homozygous loss of function (LoF) variants in SLC30A5 NM_022902.4:c.832_836del p.(Ile278Phefs*33) and NM_022902.4:c.1981_1982del p.(His661Tyrfs*10). Knockout of SLC30A5 has previously been shown a cardiac phenotype in mouse models and no homozygous LoF variants in SLC30A5 are currently described in gnomAD. Taken together, we present SLC30A5 as a new gene for a severe and perinatally lethal form of cardiomyopathy.
Keyphrases
- copy number
- heart failure
- hiv infected
- end stage renal disease
- genome wide
- pregnant women
- ejection fraction
- newly diagnosed
- primary care
- mouse model
- chronic kidney disease
- antiretroviral therapy
- photodynamic therapy
- left ventricular
- risk factors
- prognostic factors
- young adults
- dna methylation
- type diabetes
- cardiovascular events
- early onset
- coronary artery disease
- mesenchymal stem cells
- human immunodeficiency virus
- gene expression
- atomic force microscopy
- atrial fibrillation
- bone marrow
- smoking cessation
- high resolution
- cell therapy
- drug induced